Cell mediated rejection revisited: Past, current, and future directions
- PMID: 29968416
- DOI: 10.1111/nep.13283
Cell mediated rejection revisited: Past, current, and future directions
Abstract
The Banff histopathology classification system is the gold standard for assessing the causes of kidney allograft dysfunction triggered by antibody-mediated and T-cell-mediated immune reactions, thereby providing mechanistic insight and guiding therapeutic decisions. The original Banff classification (1993) consisted of four histological categories representing cell-mediated rejection: interstitial inflammation (i), tubulitis (t), endoarteritis (v), and transplant glomerulitis (g). The revised Banff 2007 classification added total inflammation score (ti) from both scarred and unscarred areas based on evolving interpretations of interstitial infiltrates. Further reappraisal of cell-mediated interstitial inflammation led to the introduction of a new inflammation score specific for areas of interstitial fibrosis and tubular atrophy, termed i-IF/TA, in the Banff 2015 scheme, establishment of a new Banff working group on T-cell-mediated rejection (TCMR), and revised criteria of chronic active TCMR in Banff 2017 classification. These Banff scheme updates reflect the general recognition that chronic interstitial inflammation is a common denominator of poor kidney allograft outcome. However, revised theories on the pathogenic importance of interstitial infiltrates have created difficulties in interpretation of chronic tubulointerstitial inflammation, as there are currently no histological criteria to discriminate immune-mediated tissue injury from 'non-specific' injury. Evolving theories on vascular lesions, both active and chronic, have also complicated histological assessment by obscuring the distinction between antibody-mediated and T-cell-mediated tissue injury. This review provides an overview of recent ideas on interstitial inflammation and vascular lesions based on emerging concepts of T-cell-mediated rejection.
Keywords: Banff classification; chronic rejection; interstitial fibrosis and tubular atrophy; interstitial inflammation; tubulitis.
© 2018 Asian Pacific Society of Nephrology.
Similar articles
-
Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection.Hum Pathol. 2018 Jun;76:47-51. doi: 10.1016/j.humpath.2018.02.016. Epub 2018 Mar 6. Hum Pathol. 2018. PMID: 29501487
-
A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.Transplantation. 2015 Aug;99(8):1691-9. doi: 10.1097/TP.0000000000000694. Transplantation. 2015. PMID: 25803498
-
T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.Am J Transplant. 2018 Feb;18(2):377-390. doi: 10.1111/ajt.14565. Epub 2017 Nov 21. Am J Transplant. 2018. PMID: 29086461
-
Banff 2013 update: Pearls and pitfalls in transplant renal pathology.Nephrology (Carlton). 2015 Jul;20 Suppl 2:2-8. doi: 10.1111/nep.12474. Nephrology (Carlton). 2015. PMID: 26031578 Review.
-
Challenges Posed by the Banff Classification: Diagnosis and Treatment of Chronic Active T-Cell-Mediated Rejection.Nephron. 2023;147 Suppl 1:74-79. doi: 10.1159/000530158. Epub 2023 Mar 16. Nephron. 2023. PMID: 36928337 Review.
Cited by
-
The Potential Diagnostic Value of Immune-Related Genes in Interstitial Fibrosis and Tubular Atrophy after Kidney Transplantation.J Immunol Res. 2022 Jun 17;2022:7212852. doi: 10.1155/2022/7212852. eCollection 2022. J Immunol Res. 2022. PMID: 35755170 Free PMC article.
-
Small Molecule Inhibitors of Lymphocyte Perforin as Focused Immunosuppressants for Infection and Autoimmunity.J Med Chem. 2022 Nov 10;65(21):14305-14325. doi: 10.1021/acs.jmedchem.2c01338. Epub 2022 Oct 20. J Med Chem. 2022. PMID: 36263926 Free PMC article. Review.
-
Antibody-mediated rejection of renal allografts: diagnostic pitfalls and challenges.Physiol Res. 2021 Dec 30;70(Suppl4):S551-S565. doi: 10.33549/physiolres.934801. Physiol Res. 2021. PMID: 35199543 Free PMC article. Review.
-
Urinary nanosensors of early transplant rejection.Nat Biomed Eng. 2019 Apr;3(4):251-252. doi: 10.1038/s41551-019-0389-0. Nat Biomed Eng. 2019. PMID: 30952984 Free PMC article.
-
Evolution of human kidney allograft pathology diagnostics through 30 years of the Banff classification process.World J Transplant. 2023 Sep 18;13(5):221-238. doi: 10.5500/wjt.v13.i5.221. World J Transplant. 2023. PMID: 37746037 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous